Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary share ADRs of GlaxoSmithKline plc purchased at a price of $44.143 per ADR on 7 July 2011, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 7 July 2011.
Director/PDMR
|
Number of ADR's |
Connected Person |
Number of ADR's |
Dr M M Slaoui
|
296.002 |
Dr K Slaoui |
8.757 |
Mr W C Louv |
198.072 |
- |
- |
Dr D Pulman
|
256.516 |
- |
- |
The Company was advised of this information on 13 July 2011.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
13 July 2011